Ribavirin dose reduction during telaprevir/ribavirin/peg‐interferon therapy overcomes the effect of the ITPA gene polymorphism
S Akamatsu, CN Hayes, M Tsuge… - Journal of Viral …, 2015 - Wiley Online Library
Treatment success of chronic hepatitis C virus genotype 1 infection has improved with the
advent of telaprevir plus peg‐interferon/ribavirin triple combination therapy. However, the …
advent of telaprevir plus peg‐interferon/ribavirin triple combination therapy. However, the …
[HTML][HTML] Aproximación para establecer y evaluar la relevancia clínica de las interacciones medicamentosas en el tratamiento de pacientes infectados con virus de …
D Pino-Marín, N Giraldo, P Amariles - Revista colombiana de …, 2016 - scielo.org.co
Objetivo: establecer y evaluarla relevancia clínica de interacciones medicamentosas en el
tratamiento de pacientes con hepatitis C genotipo 1. Método: se realizó una búsqueda en …
tratamiento de pacientes con hepatitis C genotipo 1. Método: se realizó una búsqueda en …
Antiviral therapy for chronic hepatitis C in 2014
M Nookathota, S Mukherjee - Expert Review of Clinical …, 2014 - Taylor & Francis
An all-oral therapy for treating hepatitis C (HCV) is now available for the most common
genotypes although interferon-based therapy is still recommended for interferon-eligible …
genotypes although interferon-based therapy is still recommended for interferon-eligible …
[HTML][HTML] A Structured Review of Approaches for Establishing and Evaluating Clinical Relevance of Drug Interactions in Patients with Hepatitis C Virus Genotype 1
D Pino-Marín, N Giraldo, P Amariles - Revista colombiana de …, 2016 - scielo.org.co
Abstract PINO-MARIN, Daniel; GIRALDO, Newar and AMARILES, Pedro. A Structured
Review of Approaches for Establishing and Evaluating Clinical Relevance of Drug …
Review of Approaches for Establishing and Evaluating Clinical Relevance of Drug …
From discovery to cure, a great journey of the Hepatitis C Virus study
Z Yi, Z Yuan - Infectious Diseases & Immunity, 2022 - journals.lww.com
Hepatitis C virus (HCV) causes chronic infection in over 75% of the HCV-infected
individuals, resulting in liver cancer in substantial patients. Since its discovery in 1989, HCV …
individuals, resulting in liver cancer in substantial patients. Since its discovery in 1989, HCV …
丙型肝炎直接抗病毒药物的临床研究进展
卢捷， 谢青 - 药学进展, 2018 - pps.cpu.edu.cn
全口服的直接抗病毒药物(DAA) 的上市是丙型肝炎治疗史上的重要里程碑.
在中国目前已经或即将获批上市的DAA 包括达拉他韦, 阿舒瑞韦, 索磷布韦, 奥比帕利 …
在中国目前已经或即将获批上市的DAA 包括达拉他韦, 阿舒瑞韦, 索磷布韦, 奥比帕利 …
Behandlung der HCV-Reinfektionshepatitis nach Lebertransplantation
S Bayraktar - 2021 - refubium.fu-berlin.de
Zusammenfassung Einleitung: Die Behandlung der HCV-Reinfektion nach
Lebertransplantation hat sich in den vergangenen Jahren dynamisch entwickelt. Ziel ist die …
Lebertransplantation hat sich in den vergangenen Jahren dynamisch entwickelt. Ziel ist die …
[HTML][HTML] Assessment of Bioequivalence and Safety of a Generic Sofosbuvir Product in Healthy Chinese Volunteers under Fasting and Fed Conditions
X Li, S Guo, Y Liu, P Zhang, B Xu, Y Li… - Journal of Exploratory …, 2020 - xiahepublishing.com
Methods In this single-dose, randomized, open-label, two-sequence, four-period, crossover
study, 52 healthy adult Chinese volunteers were enrolled for the fasting (n= 26) and fed (n …
study, 52 healthy adult Chinese volunteers were enrolled for the fasting (n= 26) and fed (n …
[PDF][PDF] Outcome of Sofosbuvir and Ribavirin based treatment in genotype 3 of cirrhotic chronic hepatitis C patients
RN Khan, AB Rather, M Rashid, G Javaid - academia.edu
Introduction: Hepatitis C virus is a leading cause of chronic liver disease in both
industrialized and developing countries. Considering the high prevelance of chronically …
industrialized and developing countries. Considering the high prevelance of chronically …
The pharmacogenomics of hepatitis C: optimizing effectiveness and safety on treatment
JJ Lin - 2021 - open.library.ubc.ca
Hepatitis C infection affects an estimated 71 million people globally and is responsible for
399,000 fatalities annually. Research advancing hepatitis C treatment practices are rapidly …
399,000 fatalities annually. Research advancing hepatitis C treatment practices are rapidly …